Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Disclosure The authors declare that they have no conflicts of interest in this work
Systemic Wnt pathway activation through oral or injectable drugs would raise more significant concerns than localized topical application
MAO inhibitor use
These cases demonstrate the utility of GLP-1 agonists in treating dermatologic conditions that are refractory to other therapies and further highlight the potential of GLP-1 agonists in treating skin disease
For a more comprehensive overview on accumulators and maximizers, see Section 6.2.2
US$ 27.03
US$ 29.19
US$ 21.65
